Van has a 19-year career in healthcare, technology, and management consulting. Prior to Healthagen, Van led finance and business development for AuraSense, a biotechnology company founded by world-renowned nanomedicine authority, Dr. Chad Mirkin, and funded by AbbVie Biotech Ventures and Bill Gates, among others. The company has developed a broad array of nanoparticle-based genetic therapies and diagnostic platforms, with applications in cancer and autoimmune conditions. Prior to AuraSense, Mr. Crocker was with Booz & Company, focusing on payer/provider clients.
Louis’ career spans more than 20 years working in a variety of ascending positions in sales, marketing, and managed care with GlaxoSmithKline and Meda pharmaceuticals. He launched and managed eleven brands while handling provider and consumer strategy. Lou led a variety of marketing, sales, and business development teams. Prior to joining Healthagen, he was an executive team member for a patient engagement and recruitment company, QualityHealth, where he was responsible for marketing, innovation, and business development. His work significantly contributed to the company’s growth and subsequent sale to Sharecare.
Shawn has been at Aetna since 1998. He has more than 22 years of experience in healthcare and has held a number of strategic leadership roles that span from Consumer Business to National Business including roles in Medicare and Pharmacy. Each of these roles focused on strategically important business transformation efforts. Just prior to joining the Healthagen team, Shawn led the development, negotiation, and ultimately the multi-year implementation of the Medicare portion of the Pharmacy Benefit Management agreement with CVS Health. Shawn obtained a BS degree in Business Administration from Rider University and an MBA in Finance from Rutgers University.